Search Results 681-690 of 16395 for monoclonal antibody
... monoclonal antibody targeting MISIIR. Oncotarget. 2017 Oct 17; 8 (49):85214-85223 Epub 2017 July 27. View PubMed; Bogani G, Gostout BS, Dowdy SC, Multinu F ...
To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody ... monoclonal antibody, or Interleukin-2 (IL-2) co ...
Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Cobimetinib may stop the growth of tumor ...
Mayo Clinic's world-renowned MOGAD teams include pediatric and adult neurologists, neuro-ophthalmologists, physical medicine and rehabilitation specialists ...
Prior use of monoclonal antibody within 4 weeks before Cycle 1, Day 1 · Treatment with radiotherapy, thalidomide, lenalidomide, bortezomib, any chemotherapeutic ...
The purpose of this study is to determine the efficacy of pembrolizumab in patients with advanced sarcomas. Participation eligibility. Participant eligibility ...
Monoclonal antibodies, such as cetuximab, can interfere with tumor growth by blocking the ability of tumor cells to grow and spread. Tivantinib may stop the ...
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
Research. Mayo Clinic researchers are working to improve the diagnosis and treatment of MOGAD . Specific efforts include increasing the recognition on how ...
COVID-19 Patient Acceptance to Monoclonal Antibody Infusion: A Single Medical Center Experience. South Med J 2021 Aug; 114 (8):464. View PubMed; Ghoz H ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.